CEL-SCI.COM: Keyword Density Checker

Total words: 2125 | 2-word phrases: 556 | 3-word phrases: 618 | 4-word phrases: 641

PAGE INFO

Title	Try to keep the title under 60 characters (28 characters) Cel Sci – Cel Sci Corp
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (120 characters) Dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases.

#	Keyword	Frequency	Density
1	phase 3 trial	4	0.65%
2	autoimmune and infectious	3	0.49%
3	the treatment of	3	0.49%
4	the phase 3	3	0.49%
5	treatment of cancer	3	0.49%
6	view asco 2022	3	0.49%
7	and infectious diseases	3	0.49%
8	2022 abstract on	2	0.32%
9	multikine treatment regimen	2	0.32%
10	our stakeholders by	2	0.32%
11	for our stakeholders	2	0.32%
12	unmet medical needs	2	0.32%
13	real value for	2	0.32%
14	create real value	2	0.32%
15	to create real	2	0.32%
16	of celsci’s mission	2	0.32%
17	address unmet medical	2	0.32%
18	to change the	2	0.32%
19	cancer is treated	2	0.32%
20	way cancer is	2	0.32%
21	research and development	2	0.32%
22	the root of	2	0.32%
23	celscis vision is	2	0.32%
24	the ravages of	2	0.32%
25	on the phase	2	0.32%
26	3 trial results	2	0.32%
27	results view asco	2	0.32%
28	asco 2022 abstract	2	0.32%
29	root of celsci’s	2	0.32%
30	value for our	2	0.32%

#	Keyword	Frequency	Density
1	the phase 3 trial	3	0.47%
2	autoimmune and infectious diseases	3	0.47%
3	address unmet medical needs	2	0.31%
4	value for our stakeholders	2	0.31%
5	way cancer is treated	2	0.31%
6	asco 2022 abstract on	2	0.31%
7	view asco 2022 abstract	2	0.31%
8	results view asco 2022	2	0.31%
9	real value for our	2	0.31%
10	root of celsci’s mission	2	0.31%
11	system to fight disease	2	0.31%
12	phase 3 trial results	2	0.31%
13	for our stakeholders by	2	0.31%
14	on the phase 3	2	0.31%
15	the treatment of cancer	2	0.31%
16	the root of celsci’s	2	0.31%
17	exceeding the protocol required	2	0.31%
18	create real value for	2	0.31%
19	to create real value	2	0.31%
20	the phase iii trial	2	0.31%
21	to fight disease thats	2	0.31%
22	the fda for multikine	1	0.16%
23	to the fda for	1	0.16%
24	to submit a blanda	1	0.16%
25	fda for multikine celscis	1	0.16%
26	for multikine celscis vision	1	0.16%
27	multikine celscis vision is	1	0.16%
28	application to the fda	1	0.16%
29	home about us business	1	0.16%
30	planning to submit a	1	0.16%
31	is planning to submit	1	0.16%
32	trial celsci is planning	1	0.16%
33	iii trial celsci is	1	0.16%
34	phase iii trial celsci	1	0.16%
35	from the phase iii	1	0.16%
36	and the excellent results	1	0.16%
37	worldwide and the excellent	1	0.16%
38	210000 worldwide and the	1	0.16%
39	about 210000 worldwide and	1	0.16%
40	celsci is planning to	1	0.16%

#	URL	Whois	Check
1	https://meetings.asco.org/abstracts-presentations/207201	Whois	asco.org
2	https://meetings.asco.org/abstracts-presentations/207201	Whois	asco.org
3	https://meetings.asco.org/abstracts-presentations/207202	Whois	asco.org
4	https://meetings.asco.org/abstracts-presentations/207202	Whois	asco.org
5	https://www.facebook.com/celscicorp/	Whois	facebook.com
6	https://www.google.com/maps?cid=7487150082225557228&_ga=2.177404389.1917861597.1539210330-1305626423.1522690308	Whois	google.com
7	https://twitter.com/CelSciCorp	Whois	twitter.com
8	https://www.linkedin.com/company/cel-sci-corporation/	Whois	linkedin.com
9	https://accessibility-helper.co.il/	Whois	co.il